Welcome to PsychU!

Quality Standards & Performance Measures

Quality standards allow performance to be measured, and measuring performance is the first step to improving behavioral health care and outcomes for individuals. Visit this library for the latest in performance metrics and quality benchmarks.

Featured Resources

HHS Mental Health Strategy Calls For Transforming Health & Social Services To Support Equitable & Holistic Care

HHS Mental Health Strategy Calls For Transforming Health & Social Services To Support Equitable & Holistic Care

On March 1, 2022, President Biden and the U.S. Department of Health and Human Services (HHS) announced a new national mental health strategy. This effort, called the National Tour to Strengthen Mental Health, calls for transforming the health and social services infrastructure to address mental health holistically and equitably. The…
Acquiring A Medical Marijuana Card Linked To Development Of Cannabis Use Disorder Within 12 Weeks

Acquiring A Medical Marijuana Card Linked To Development Of Cannabis Use Disorder Within 12 Weeks

About 17% of adults ages 18 to 65 diagnosed with insomnia, pain, or anxiety who obtained medical marijuana cards immediately after receiving a qualifying diagnosis developed cannabis use disorder in the first 12 weeks. Among a similarly diagnosed group who waited 12 weeks before obtaining a medical marijuana card, 8.6%…

Upcoming Events

Ask A Question About Quality Standards & Performance Measures

Enter your question in the box below and click “Ask My Question” to submit your inquiry.

You must be logged in to ask a question in this section.

Disclaimer: The information provided by PsychU is intended for your educational benefit only. It is not intended as, nor is it a substitute for medical care or advice or professional diagnosis. Treatment-related questions will not be addressed. Users seeking medical advice should consult with their physician or other healthcare professional.

Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) operates in a highly regulated and scrutinized industry. Therefore, we may not be able to address every questions or topic submitted. Topics which may not be addressed may include, but are not limited to questions related to: (1) specific medications, (2) branded items, (3) clinical or treatment advice relating to specific patient conditions. The lack of response to certain questions or comments should not be taken as an agreement with the view posed or an admission of any kind.

REQUEST A PRESENTATION

Request a free educational program for your organization or region today! These customizable PsychU presentations are available both online and in-person, and cover a range of topics including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and more.

Top Requested Presentations

The Neuropsychiatric Inventory: Development & Applications

Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Learning Tracks